COMMUNIQUÉS West-GlobeNewswire

Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
18/08/2026
Dr. Camisasca joins Entera with 30 years of global pharmaceutical research and clinical development experience including roles at Sumitomo Pharma, Takeda, and Novartis Appointment further strengthens Entera’s clinical [...]
PROMIXX Pursuit Insulated Shaker Bottle Keeps Protein Shakes Ice Cold for 12+ Hours, Outlasting Standard Gym Bottles
18/08/2026
Dual wall vacuum insulated design is built for full gym sessions, commutes and all day use, without the drink going warm CARDIFF, United Kingdom, Aug. 18, 2026 (GLOBE NEWSWIRE) -- As gym sessions run longer through the [...]
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
18/08/2026
Primary endpoint achieved, demonstrating a 70% economic advantage over allograft based on product cost per percent total body surface area treated (p<0.001) 96% reduction in preparation time and comparable clinical [...]
BrewDog Unwraps Its 2026 Advent Calendar
18/08/2026
New brews, bold flavours and one unmissable 24-day countdown to Christmas ELLON, United Kingdom, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Scottish craft brewer BrewDog , by Tilray Brands, Inc. , today unveiled its 2026 Advent [...]
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
18/08/2026
Total revenue of $46.5 million, up ~288% YoY (~3.9x); within the Company’s guidance of $46-48 million IM8 revenue of $45.0 million, up ~359% YoY (~4.6x); within the Company’s guidance of $44-46 million, marking the [...]
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
18/08/2026
Former Intra-Cellular Therapies, Inc. (“Intra-Cellular”) executives bring complementary experience in organizational scale-up, central nervous system (“CNS”) drug development, regulatory approvals and commercialization [...]
General Oncology Nominated for the 2026 Prix Galien USA Best Startup Award
18/08/2026
Recognition follows preliminary Phase 1 results presented at ESMO Congress 2025 for GO-4 in BRCA/PALB2-mutated stage IV pancreatic ductal adenocarcinoma, where two patients remain progression-free at 48 and 23 months [...]
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
18/08/2026
PRESS RELEASE CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor LONDON – 18 August 2026 -- CHARM Therapeutics (“CHARM”, “The Company [...]
Immatics Announces Second Quarter 2026 Financial Results and Business Update
18/08/2026
Enrollment in the SUPRAME Phase 3 trial of anzu-cel (anzutresgene autoleucel, IMA203) remains on track to complete the required randomizations by year-end to support final analysis for the primary PFS endpoint; [...]
ABBYY’s New Executive Appointments Illustrate Focus on Hybrid AI to Drive Enterprise Intelligence
18/08/2026
Robert Hucik promoted to Chief Technology Officer and Joe Rayfield hired as SVP of Sales for the Americas and EMEA AUSTIN, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ABBYY today announced it promoted Robert Hucik to Chief [...]
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
18/08/2026
As a global medical cannabis leader, Tilray Medical supports continued policy development that strengthens physician confidence, protects patient access and provides a clear, sustainable framework for medical cannabis [...]
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
18/08/2026
Asimov will use its CHO Edge System to develop a high-titer cell line for Kaigene’s novel multispecific antibody that selectively degrades pathogenic antibodies. BOSTON, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Asimov, the [...]
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC
18/08/2026
SAN DIEGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative [...]
Peak Physio Launches Subscription Education Platform Arcane Physio for International Clinician Market
18/08/2026
Physiotherapist Laith Cunneen on Channel 7’s Sunrise. Supplied by Arcane Physio Peak Physio has opened Arcane Physio, a clinical education and reference platform, to external subscribers, targeting physiotherapists [...]
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
18/08/2026
Peer-reviewed research points to the extracellular matrix, the framework that holds tissue together, as central to that work. More than a decade of research has gone into Conexeu’s CXU™ Platform Highlights Regenerative [...]
Polomar Health Services Reports Second-Quarter Revenue of $1.53 Million and Positive Net Income
18/08/2026
Commercial prescription fulfillment drives significant revenue growth, a 61.2% gross margin and improved operating cash flow PALM HARBOR, Fla., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Polomar Health Services, Inc. (OTCQB: [...]
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
18/08/2026
Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom and Republic of Ireland TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “ [...]
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
18/08/2026
Avance Clinical to Lead Preparatory Activities for Multi-Center Investigation Across Australia MELBOURNE, Australia, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company [...]
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufacturing Center
18/08/2026
Kennewick, WA, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of cancerous tumors, today announced two [...]

Pages